BIOMAT Database Logo BIOMAT Database Logo

Procainamide: autoimmune phenomena and acetylator phenotype. 1985

R E Bernstein

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011342 Procainamide A class Ia antiarrhythmic drug that is structurally-related to PROCAINE. Procaine Amide,Apo-Procainamide,Biocoryl,Novocainamide,Novocamid,Procainamide Hydrochloride,Procamide,Procan,Procan SR,Procanbid,Pronestyl,Rhythmin,Amide, Procaine,Hydrochloride, Procainamide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune

Related Publications

R E Bernstein
Acetylator phenotype and the clinical pharmacology of slow-release procainamide.
December 1976, British journal of clinical pharmacology,
R E Bernstein
[Pharmacokinetics of procainamide and its metabolite depending on acetylator phenotype].
January 1992, Polski tygodnik lekarski (Warsaw, Poland : 1960),
R E Bernstein
Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype.
February 1979, Journal of pharmacokinetics and biopharmaceutics,
R E Bernstein
Significance of acetylator phenotype in pharmacokinetics and adverse effects of procainamide.
January 1983, European journal of clinical pharmacology,
R E Bernstein
Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide.
January 1979, Acta medica Scandinavica,
R E Bernstein
Determination of procainamide acetylator status.
January 1978, Clinical pharmacology and therapeutics,
R E Bernstein
[Autoimmune phenomena and female phenotype gonadal dysgenesis].
April 1966, Rassegna di neurologia vegetativa,
R E Bernstein
Ageing and acetylator phenotype.
January 1985, European journal of clinical pharmacology,
R E Bernstein
Endralazine and acetylator phenotype.
May 1983, Lancet (London, England),
R E Bernstein
Isoniazid acetylator phenotype.
February 1989, Indian pediatrics,
Copied contents to your clipboard!